EPS & Dividend: Sanofi

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Dividend per Share 2 3.15 3.2 3.33 3.56 3.76 3.842 4.064 4.472
Rate of return 3.51% 4.07% 3.76% 3.96% 4.19% 3.67% 3.89% 4.28%
EPS 2 2.24 9.82 4.97 5.37 4.31 5.261 6.701 7.541
Distribution rate 141% 32.6% 67% 66.3% 87.2% 73% 60.6% 59.3%
Reference price 2 89.62 78.70 88.58 89.84 89.76 104.54 104.54 104.54
Nbr of stocks (in thousands) 1,253,178 1,256,375 1,255,293 1,254,060 1,253,891 1,253,277 - -
Announcement Date 06/02/20 05/02/21 04/02/22 03/02/23 01/02/24 - - -
1EUR in Million2EUR
Estimates

Past dividends: Sanofi

12/05/2024 Annual 3.76 EUR
29/05/2023 Annual 3.56 EUR
05/05/2022 Annual 3.33 EUR
04/05/2021 Annual 3.2 EUR
03/05/2020 Annual 3.15 EUR
08/05/2019 Annual 3.07 EUR
10/05/2018 Annual 3.03 EUR
15/05/2017 Annual 2.96 EUR
09/05/2016 Annual 2.93 EUR
10/05/2015 Annual 2.85 EUR

Upcoming events: Sanofi

18/09/2024 11:00 UBS Bus Tour
19/09/2024 07:00 Bank of America Global Healthcare Conference
20/09/2024 10:00 Wolfe Research “Pipelines Unplugged” Conference
23/09/2024 14:00 Citi's European Healthcare Bus Tour
22/10/2024 06:00 BioProcess International Asia
25/10/2024 06:30 Q3 2024 Earnings Release
25/10/2024 13:00 Q3 2024 Earnings Call
30/01/2025 Q4 2024 Earnings Release (Projected)
23/04/2025 Q1 2025 Earnings Release (Projected)
23/07/2025 Q2 2025 Earnings Release (Projected)
23/10/2025 Q3 2025 Earnings Release (Projected)
More events

Add to a list
Yield (Y) Yield (Y+1) P/E ratio Price to Book EV / Sales
+3.67%+3.88%19.88x 1.713 2.94x
+0.58%+0.66%58.18x 40.10 18.04x
+1.29%+1.71%38.81x 27.20 13.49x
+2.85%+3.12%21.05x 5.601 4.55x
+3.22%+3.33%37.64x 40.88 7.13x
+2.61%+2.74%15.71x 6.086 4.99x
+3.59%+3.69%16.36x 6.070 3.88x
+1.85%+1.97%29.75x 6.131 5.34x
+3.22%+3.34%21.17x 5.316 5.01x
+2.86%+3.09%48.68x 34.31 6.7x
Average +2.57% +2.75% 30.72x 17.34 7.21x
Weighted average by Cap. +2.12% +2.31% 35.37x 21.97 9.53x
See all sector dividends

Dividend / Share (DPS) - Evolution of Analysts' Estimates

Dividend / Share (DPS) - Estimates Revisions

Estimates Revisions:
More analyst reviews

Earnings Per Share (EPS) - Evolution of Analysts' Estimates

Annual Profit -

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW